Dacuronium bromide
 | |
| Identifiers | |
|---|---|
| |
| Synonyms | NB-68; 17β-Hydroxypancuronium bromide; 3α-(Acetyloxy)-17β-hydroxy-2β,16β-bis(1-methylpiperidinium-1-yl)-5α-androstane dibromide; 2β,16β-Dipiperidino-5α-androstane-3α,17β-diol 3α-acetate dimethobromide |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C33H58Br2N2O3 |
| Molar mass | 690.65 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Dacuronium bromide (INN, BAN) (developmental code name NB-68) is an aminosteroid neuromuscular blocking agent which was never marketed.[1][2][3][4][5] It acts as a competitive antagonist of the nicotinic acetylcholine receptor (nAChR).[2]
References
- ↑ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 647–. ISBN 978-1-4757-2085-3.
- 1 2 I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 90–. ISBN 978-94-011-4439-1.
- ↑ Progress in Medicinal Chemistry. Elsevier. 1 January 1979. pp. 102–. ISBN 978-0-08-086264-4.
- ↑ R.E.M. Bowden; B. Collier; R.D. Dripps; L.W. Duchen, G.E. Hale Enderby, B.L. Ginsborg, S. Head, F. Hobbiger, D.H. Jenkinson, F.C. MacIntosh, S.E. Smith (13 March 2013). Neuromuscular Junction. Springer Science & Business Media. pp. 421–. ISBN 978-3-642-45476-9.
- ↑ Dimitry A. Kharkevich (6 December 2012). New Neuromuscular Blocking Agents: Basic and Applied Aspects. Springer Science & Business Media. pp. 201–202,213. ISBN 978-3-642-70682-0.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.